The company behind the complete genome.
Dante Labs sequences the complete genome and interprets it clinically — delivering results a physician can act on. From clinical-grade sequencing to AI-powered analysis, everything is built to help you and your physician make informed decisions together.
Built for the questions that standard testing wasn't designed to answer.
Some genetic questions require more than a targeted test can provide. A family history that spans multiple conditions. A diagnosis that's confirmed but doesn't explain why a treatment isn't working. A set of symptoms that doesn't match any single-gene panel. Whole genome sequencing was built for these situations — because it reads the full genome, not a pre-selected subset.
Dante's job is to make that capability accessible — at a price point that does not require a research institution, with clinical-grade accuracy, and with results that help you and your physician make informed decisions together.
The name reflects the founding intent — "Dante" after the Italian poet who made the complex comprehensible; "Labs" for the clinical science that makes it possible.
Andrea Riposati
Chief Executive Officer & Co-founder
Andrea co-founded Dante Labs in 2016 after seeing how long it took clinical genomics to reach the people who needed it most. His goal was direct: make whole genome sequencing clinically accessible — with results a physician can act on, at a cost that doesn't require institutional backing.
Before Dante, Andrea launched 3D Printing at Amazon, built marketplace algorithms at Amazon Business, and consulted at Booz & Company. He holds an MBA from Harvard Business School and was on the teaching faculty at Harvard's Department of Economics.
He was named EY Entrepreneur of the Year (2019), is a member of the Forbes Technology Council, and Dante has been recognized in the Financial Times Top 25 European Fastest Growing Companies and Sole 24 Ore Growth Leaders.
Watch Andrea present at Italian Tech Week 2023Science held to the standard medicine already trusts.
Sequenced in ISO 15189-accredited laboratories in Europe and the United States. CLIA-certified and CAP-accredited. Classified to ACMG standards — the same framework used by Mayo Clinic, Johns Hopkins, and NHS Genetics. Published in Nature Communications.
Accredited by & published in
Where we operate.
Headquarters
Dante Labs is headquartered in New York City, with offices across Europe and the Middle East.
Laboratory Operations
Sequencing is performed in ISO 15189-accredited, CLIA-certified, and CAP-accredited laboratories in Europe and the United States. All data handling is protected by GDPR — one of the strongest privacy frameworks in the world.
Global Reach
Customers and clinical partners in over 100 countries. Reports are structured so physicians anywhere in the world can use them directly for clinical decisions.
"The diagnosis was life-changing. Today my daughter is living a better life."
One test.
A lifetime of answers.
One kit, sent to your home. Your entire genome sequenced at the clinical standard used for diagnostic decisions. 200+ physician-ready reports delivered to your Genome Manager in 6–8 weeks — permanent and updated as science advances.
Ships within 48 hours · Results in 6–8 weeks
